Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association

Research has shown that getting to glycemic targets early on leads to better outcomes in people with type 2 diabetes; yet, there has been no improvement in the attainment of A1C targets in the past decade. One reason is therapeutic inertia: the lack of timely adjustment to the treatment regimen when...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabbay, Robert A., Kendall, Debbie, Beebe, Christine, Cuddeback, John, Hobbs, Todd, Khan, Naeem D., Leal, Sandra, Miller, Eden, Novak, Lucia M., Rajpathak, Swapnil N., Scribner, Paul, Meneghini, Luigi, Khunti, Kamlesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Perspectives in Clinical Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566926/
https://www.ncbi.nlm.nih.gov/pubmed/33132507
http://dx.doi.org/10.2337/cd20-0053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566926/
https://www.ncbi.nlm.nih.gov/pubmed/33132507
http://dx.doi.org/10.2337/cd20-0053

Ejemplares similares